Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibo…

Overview of attention for article published in Frontiers in Neurology, August 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 1 Reddit thread.

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.